Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS’ DEFICIT (Details 1)

v2.4.0.8
STOCKHOLDERS’ DEFICIT (Details 1) (USD $)
3 Months Ended 9 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Stock-based compensation expenses $ 293,500 $ 340,200 $ 987,000 $ 1,010,700
Cost Of Neurometric Services Revenues[Member]
       
Stock-based compensation expenses 2,700 2,500 7,900 7,600
Research Tax Credit Carryforward [Member]
       
Stock-based compensation expenses 21,900 24,000 70,800 75,200
Product Development [Member]
       
Stock-based compensation expenses 33,600 19,000 82,600 53,600
Selling and Marketing Expense [Member]
       
Stock-based compensation expenses 30,300 49,500 129,400 147,400
General and Administrative Expense [Member]
       
Stock-based compensation expenses $ 205,000 $ 245,200 $ 696,300 $ 726,900